Terns Pharmaceuticals gets FDA breakthrough status for leukemia drug
Original source: https://www.investing.com/news/stock-market-news/terns-pharmaceuticals-gets-fda-breakthrough-status-for-leukemia-drug-93CH-4638656
Read More »US FDA rejects AbbVie’s wrinkle treatment due to manufacturing concerns
Original source: https://www.investing.com/news/stock-market-news/us-fda-rejects-abbvies-wrinkle-treatment-due-to-manufacturing-concerns-4634072
Read More »Rare disease advocacy group urges Trump administration to restore FDA clarity
Original source: https://www.investing.com/news/stock-market-news/rare-disease-advocacy-group-urges-trump-administration-to-restore-fda-clarity-4593097
Read More »FDA vaccines chief Vinay Prasad to leave regulator in April
Original source: https://www.investing.com/news/stock-market-news/fda-vaccines-chief-vinay-prasad-to-step-down-in-april-4548059
Read More »US FDA’s operations chief to retire, 30-year agency veteran to succeed
Original source: https://www.investing.com/news/stock-market-news/us-fdas-operations-chief-to-retire-30year-agency-veteran-to-succeed-4542080
Read More »US FDA warns Novo again about misleading drug advertising
Original source: https://www.investing.com/news/stock-market-news/us-fda-warns-novo-for-second-time-about-misleading-drug-advertising-4539343
Read More »Vanda Pharmaceuticals stock surges after the FDA approves its new Bipolar I drug
Original source: https://www.investing.com/news/stock-market-news/vanda-pharmaceuticals-stock-surges-after-the-fda-approves-its-new-bipolar-i-drug-4517428
Read More »FDA refuses to review Moderna’s influenza vaccine application
Original source: https://www.investing.com/news/stock-market-news/fda-refuses-to-review-modernas-influenza-vaccine-application-4498531
Read More »Hims & Hers to stop offering compounded semaglutide pill after FDA crackdown
Original source: https://www.investing.com/news/stock-market-news/hims–hers-to-stop-offering-compounded-semaglutide-pill-after-fda-crackdown-4492374
Read More »US signals crackdown on compounded weight-loss drugs; Hims shares tumble
Original source: https://www.investing.com/news/stock-market-news/fda-to-restrict-glp1-ingredients-used-in-nonapproved-compounded-drugs-4492113
Read More »